1
|
Wendel P, Palacios AM, Oberoi P, Habermann J, Schoenfeld K, Gierschek F, Kolmar H, Wels WS, Ullrich E. Development of idiotype-specific vNAR-CAR-immune cells for the
treatment of clonal malignancies. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- P Wendel
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, Germany
- Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main,
Germany
| | - AM Palacios
- Institute for Organic Chemistry and Biochemistry, Technische
Universität Darmstadt, Darmstadt, Germany
| | - P Oberoi
- Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main,
Germany
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental
Therapy, Frankfurt, Germany
| | - J Habermann
- Institute for Organic Chemistry and Biochemistry, Technische
Universität Darmstadt, Darmstadt, Germany
| | - K Schoenfeld
- Institute for Organic Chemistry and Biochemistry, Technische
Universität Darmstadt, Darmstadt, Germany
| | - F Gierschek
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, Germany
- Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main,
Germany
| | - H Kolmar
- Institute for Organic Chemistry and Biochemistry, Technische
Universität Darmstadt, Darmstadt, Germany
| | - WS Wels
- Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main,
Germany
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental
Therapy, Frankfurt, Germany
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt, Germany
| | - E Ullrich
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, Germany
- Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main,
Germany
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt, Germany
- University Cancer Center (UCT) Frankfurt-Marburg, Frankfurt,
Germany
| |
Collapse
|
2
|
Heim C, Moser LM, Merker M, Wels WS, Ivics Z, Bönig H, Ullrich E, Klusmann JH, Bader P, Rettinger E. ErbB2-CAR mediated immunotherapy for the treatment of high-risk
rhabdomyosarcoma. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- C Heim
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| | - LM Moser
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| | - M Merker
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| | - WS Wels
- Mental Therapy, Frankfurt, Germany
| | - Z Ivics
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - H Bönig
- Department of Cellular Therapeutics/Cell Processing (Good
Manufacturing Practice, GMP), Institute for Transfusion Medicine and
Immunotherapy, Goethe University, Frankfurt, Germany
| | - E Ullrich
- Experimental Immunology, Department for Children and Adolescents,
University Hospital Frankfurt, Goethe University, Frankfurt,
Germany
| | - J-H Klusmann
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| | - P Bader
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| | - E Rettinger
- Division for Stem Cell Transplantation, Immunology, and Intensive Care
Medicine, Department for Children and Adolescents, University Hospital
Frankfurt, Goethe University Frankfurt, Frankfurt, Germany
| |
Collapse
|
3
|
Bexte T, Botezatu L, Miskey C, Reindl LM, Campe J, Mertlitz S, Gebel V, Schubert R, Cremer A, Rettinger E, Prommersberger S, Penack O, Wels WS, Hudecek M, Ivics Z, Ullrich E. High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty transposon vectors. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- T Bexte
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
| | - L Botezatu
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - C Miskey
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - LM Reindl
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
| | - J Campe
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
| | - S Mertlitz
- Charité Universitätsmedizin Berlin, Berlin,
Germany
| | - V Gebel
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
| | - R Schubert
- Department for Children and Adolescents, University Hospital,
Goethe-University, Frankfurt, Germany
| | - A Cremer
- Department of Hematology and Oncology, Johann Wolfgang Goethe
University, Frankfurt, Germany
| | - E Rettinger
- Division of Stem Cell Transplantation and Immunology, Department of
Children and Adolescent Medicine, Hospital of the Goethe University Frankfurt,
60590, Germany
| | - S Prommersberger
- Department of Internal Medicine II, University Hospital
Würzburg, Würzburg, Germany
| | - O Penack
- Charité Universitätsmedizin Berlin, Berlin,
Germany
| | - WS Wels
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental
Therapy, Frankfurt am Main, Germany
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt am Main, Germany
| | - M Hudecek
- Department of Internal Medicine II, University Hospital
Würzburg, Würzburg, Germany
| | - Z Ivics
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - E Ullrich
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt am Main, Germany
| |
Collapse
|
4
|
Reindl LM, Grèze V, Wendel P, Särchen V, Wels WS, Vogler M, Ullrich E. Improving NK-cell immunotherapy against
rhabdomyosarcoma. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- LM Reindl
- University Hospital Frankfurt, Department for Children and Adolescents
Medicine, Experimental Immunology, Goethe University, Frankfurt,
Germany
| | - V Grèze
- University Hospital Frankfurt, Department for Children and Adolescents
Medicine, Experimental Immunology, Goethe University, Frankfurt,
Germany
| | - P Wendel
- University Hospital Frankfurt, Department for Children and Adolescents
Medicine, Experimental Immunology, Goethe University, Frankfurt,
Germany
| | - V Särchen
- Institute for Experimental Cancer Research in Pediatrics, Goethe
University, Frankfurt, Germany
| | - WS Wels
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental
Therapy, Frankfurt, Germany
| | - M Vogler
- Institute for Experimental Cancer Research in Pediatrics, Goethe
University, Frankfurt, Germany
| | - E Ullrich
- University Hospital Frankfurt, Department for Children and Adolescents
Medicine, Experimental Immunology, Goethe University, Frankfurt,
Germany
| |
Collapse
|
5
|
Albinger N, Pfeifer R, Kreyenberg H, Schubert R, Schneider D, Kühn MWM, Penack O, Zhang C, Möker N, Ullrich E. Primary CD33-targeting CAR-NK cells for the treatment of acute
myeloid leukemia. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- N Albinger
- Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe
University, Germany
| | - R Pfeifer
- Miltenyi Biotec, Bergisch Gladbach, Germany
| | | | | | | | - MWM Kühn
- University Hospital Mainz, Germany
| | - O Penack
- Charite, University Hospital Berlin, Germany
| | - C Zhang
- Miltenyi Biotec, Bergisch Gladbach, Germany
| | - N Möker
- Miltenyi Biotec, Bergisch Gladbach, Germany
| | - E Ullrich
- Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe
University, Germany
| |
Collapse
|
6
|
Nicin L, Abplanalp W, Schaenzer A, John D, Mellentin H, Tombor L, Ullrich E, Zeiher A, Rupp S, Dimmeler S. Single nuclei sequencing reveals novel insights into cardiac cell signatures in human pediatric dilated cardiopathy. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0933] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
The mechanism underlying dilated cardiomyopathy (DCM) in children without a known genetic disorder are unclear. In contrast to adult DCM patients, there is an unmet need for therapeutic options that improve survival in pediatric DCM. Therefore, we performed single nuclei RNA sequencing (snRNA-seq) from heart tissue obtained from children undergoing heart transplantation due to severe heart failure.
We processed heart tissue from 6 children with DCM (EF: 18.67±2.11%) of an age of 0.5, 0.75, 5, 6, 12 and 13 years (y). After snRNA-seq, unsupervised clustering was performed identifying 8 major cell types, including cardiomyocytes (CM), fibroblasts (FB), endothelial cells, leukocytes, pericytes, smooth muscle cells, neuronal-like cells and an endothelial-fibroblast-like cluster. Relative numbers of FB clusters correlated with increasing age of the children which was clinically validated by measuring late enhancement (LE) with cardiac magnetic resonance imaging in 68 pediatric DCM patients. The mean age of patients with LE was 5.86±0.53y vs. 2.36±0.53y in patients without LE (p<0.05). Further analysis of unique highly expressed genes (DEGs) between the 3 age groups identified a profound alteration of gene expression in FB clusters. FBs of explants of <1y old patients showed high expression of anti-fibrotic, development and remodeling associated genes. In contrast, FBs of 12–13y old children highly expressed pro-fibrotic and FB activation associated genes as transforming growth factor beta binding protein (6.63 fold), cytochrome P450 1B1 (3.79 fold), and periostin (7.67 fold) (all p<0.05). Moreover, we observed a switch in collagen expression patterns and in thrombospondin isoforms (from THBS1 to THBS4). Furthermore, our analysis revealed most profound transcriptional changes in CMs. We identified a cluster of CMs with a pro-regenerative profile in <1y old patients, which could not be detected during adolescence. This CM cluster showed high expression of genes associated with proliferation (e.g. cyclin D2), glycolytic metabolism and anti-oxidant markers. Increased cyclin D2 was confirmed by immunostaining (1.43 fold higher in <1y vs. 12–13y). Since all of these gene expression patterns might be affected by the underlying disease of the pediatric heart recipients, we explored their expression in FBs and CMs of postnatal vs. adult mice. Importantly, we could recapitulate the vast majority of the findings from humans in the mice experiments.
Together, these data demonstrate an age-dependent decrease in CM numbers concomitant with increased FBs in pediatric DCM. FBs of <1y old pediatric patients revealed a distinct collagen expression profile and showed lower levels of pro-fibrotic genes. CMs of <1y old donors where characterized with a regeneration enabling gene expression profile, which include pro-proliferative genes. The expression patterns of the CMs indicates, that regeneration might also occur in humans during the firs year of life.
Funding Acknowledgement
Type of funding source: Public grant(s) – EU funding. Main funding source(s): Dr. Rolf M. Schwiete Stiftung, DZHK
Collapse
Affiliation(s)
- L Nicin
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| | - W Abplanalp
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| | - A Schaenzer
- JL University Giessen, Institute of Neuropathology, Giessen, Germany
| | - D John
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| | - H Mellentin
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| | - L Tombor
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| | - E Ullrich
- Johann Wolfgang Goethe University, Division of Pediatric Stem Cell Transplantation, Frankfurt am Main, Germany
| | - A.M Zeiher
- Johann Wolfgang Goethe University, Medical Clinic III / Cardiology, Frankfurt am Main, Germany
| | - S Rupp
- University Hospital Giessen and Marburg, Giessen, Germany
| | - S Dimmeler
- Johann Wolfgang Goethe University, Institute for Cardiovascular Regeneration, Frankfurt am Main, Germany
| |
Collapse
|
7
|
Caf P, Kunz J, Flechsig P, Ullrich E, Reimer P, Barreto MM, Kappes J, Herth FJ, Warth A, Kauczor HU, Heußel CP. [What could the pancreas have to do with shoulder pain?]. Med Klin Intensivmed Notfmed 2017; 113:135-138. [PMID: 29119210 DOI: 10.1007/s00063-017-0374-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 08/21/2017] [Accepted: 10/08/2017] [Indexed: 10/18/2022]
Affiliation(s)
- P Caf
- Diagnostische und Interventionelle Radiologie mit Nuklearmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. .,Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. .,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland. .,Abteilung für Radiologie, Universitätsklinikum Maribor, Ljubljanska ulica 5, 2000, Maribor, Slowenien.
| | - J Kunz
- Diagnostische und Interventionelle Radiologie mit Nuklearmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - P Flechsig
- Translationale Thoraxpathologie, Pathologisches Institut, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Nuklearmedizin, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - E Ullrich
- Abteilung für Thoraxchirurgie, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - P Reimer
- Abteilung für Thoraxchirurgie, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - M Miranda Barreto
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - J Kappes
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - F J Herth
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - A Warth
- Translationale Thoraxpathologie, Pathologisches Institut, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - H-U Kauczor
- Diagnostische und Interventionelle Radiologie mit Nuklearmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| | - C P Heußel
- Diagnostische und Interventionelle Radiologie mit Nuklearmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.,Translational Lung Research Center (TLRC) Heidelberg, Deutsches Zentrum für Lungenforschung (DZL), Heidelberg, Deutschland
| |
Collapse
|
8
|
Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, Lu hr JJ, Hoffmann A, Reimer KC, Lux A, So der S, Hartmann A, Zenk J, Ulas T, McGovern N, Alexiou C, Spriewald B, Mackensen A, Schuler G, Schauf B, Forster A, Repp R, Fasching PA, Purbojo A, Cesnjevar R, Ullrich E, Ginhoux F, Schlitzer A, Nimmerjahn F, Schultze JL, Dudziak D. Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment. Sci Immunol 2016; 1:1/6/eaai7677. [DOI: 10.1126/sciimmunol.aai7677] [Citation(s) in RCA: 100] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Accepted: 11/14/2016] [Indexed: 11/02/2022]
|
9
|
Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC). Lung Cancer 2015; 91:41-7. [PMID: 26711933 DOI: 10.1016/j.lungcan.2015.11.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 11/12/2015] [Accepted: 11/21/2015] [Indexed: 12/25/2022]
Abstract
PURPOSE Current guidelines recommend postoperative radiation therapy (PORT) for incompletely resected non-small cell lung cancer (NSCLC). However, there is still a paucity of evidence for this approach. Hence, we analyzed survival in 78 patients following radiotherapy for incompletely resected NSCLC (R1) and investigated prognostic factors. PATIENTS AND METHODS All 78 patients with incompletely resected NSCLC (R1) received PORT between December 2001 and September 2014. The median total dose for PORT was 60 Gy (range 44-68 Gy). The majority of patients had locally advanced tumor stages (stage IIA (2.6%), stage IIB (19.2%), stage IIIA (57.7%) and stage IIIB (20.5%)). 21 patients (25%) received postoperative chemotherapy. RESULTS Median follow-up after radiotherapy was 17.7 months. Three-year overall (OS), progression-free (PFS), local (LPFS) and distant progression-free survival (DPFS) rates were 34.1, 29.1, 44.9 and 51.9%, respectively. OS was significantly prolonged at lower nodal status (pN0/1) and following dose-escalated PORT with total radiation doses >54 Gy (p=0.012, p=0.013). Furthermore, radiation doses >54 Gy significantly improved PFS, LPFS and DPFS (p=0.005; p=0.050, p=0.022). Interestingly, survival was neither significantly influenced by R1 localization nor by extent (localized vs. diffuse). Multivariate analyses revealed lower nodal status and radiation doses >54.0 Gy as the only independent prognostic factors for OS (p=0.021, p=0.036). CONCLUSION For incompletely resected NSCLC, PORT is used for improving local tumor control. Local progression is still the major pattern of failure. Radiation doses >54 Gy seem to support improved local control and were associated with better OS in this retrospective study.
Collapse
Affiliation(s)
- Juliane Rieber
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany
| | - Alexander Deeg
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany
| | - Elena Ullrich
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University, Heidelberg, Germany
| | - Robert Foerster
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany
| | - Marc Bischof
- Department of Radiation Oncology, Klinikum am Gesundbrunnen, SLK-Kliniken Heilbronn GmbH, Germany
| | - Arne Warth
- Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany
| | | | - Thomas Muley
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University, Heidelberg, Germany
| | - Jutta Kappes
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Pneumology, Thoraxklinik, Heidelberg University, Heidelberg, Germany
| | - Claus Peter Heussel
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik gGmbH, University Hospital Heidelberg, Heidelberg, Germany; Department of Diagnostic and Interventional Radiology, University-HospitalHeidelberg, Heidelberg, Germany
| | - Thomas Welzel
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany
| | - Michael Thomas
- Department of Thoracic Oncology, Thoraxklinik, Heidelberg University, Heidelberg, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany
| | - Martin Steins
- Department of Thoracic Oncology, Thoraxklinik, Heidelberg University, Heidelberg, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany
| | - Hendrik Dienemann
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University, Heidelberg, Germany
| | - Jürgen Debus
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany
| | - Hans Hoffmann
- Translational Research Unit, Thoraxklinik, Heidelberg University, Germany Translational Lung Research Centre Heidelberg (TLRC-H), Member of the German Centre for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University, Heidelberg, Germany
| | - Stefan Rieken
- Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany.
| |
Collapse
|
10
|
Weiss KH, Van de Moortele M, Gotthardt DN, Pfeiffenberger J, Seessle J, Ullrich E, Gielen E, Borghs H, Adriaens E, Stremmel W, Meersseman W, Boonen S, Cassiman D. Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis 2015; 38:949-56. [PMID: 25663473 DOI: 10.1007/s10545-015-9815-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Revised: 01/14/2015] [Accepted: 01/19/2015] [Indexed: 02/07/2023]
Abstract
AIMS AND BACKGROUND We compared the bone mineral density (BMD) of adult Wilson disease (WD) patients (n = 148), with an age- and gender-matched healthy control population (n = 148). Within the WD cohort, correlations of BMD with WD disease parameters, lab results, type of treatment and known osteoporosis risk factors were analysed. METHODS Hip and lumbar spine absolute BMD and T-score were measured by dual-energy X-ray absorptiometry. Osteoporosis and osteopenia were defined as a T-score ≤ -2.5, and between -1 and -2.5, respectively. RESULTS There were significantly more subjects with abnormal T-scores in the WD population (58.8%) than in the control population (45.3%) (χ(2) = 6.65, df = 2, p = 0.036), as there were 50.0% osteopenic and 8.8% osteoporotic WD patients, vs. 41.2% and 4.1%, respectively, in the controls. Especially L2-L4 spine BMD measurements (BMD and T-scores) differed significantly between the WD population and matched controls. L2-L4 spine BMD for WD patients was on average 0.054 g/cm(2) (5.1%) lower than in matched normal controls (0.995 ± 0.156 vs 1.050 ± 0.135; p = 0.002). We found no significant correlation between BMD values and any of the WD disease parameters (e.g. the severity of liver disease), lab results, type of treatment or known osteoporosis risk factors. Duration of D-penicillamine treatment was negatively correlated with femoral BMD value, but in a clinically irrelevant manner, compared to age and gender. Importantly, BMD remained significantly lower in WD patients (n = 89) vs. controls after excluding WD patients with cirrhosis (p = 0.009). CONCLUSIONS Our study suggests that WD is intrinsically associated with bone demineralisation.
Collapse
Affiliation(s)
- Karl Heinz Weiss
- Department of Internal Medicine IV, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany,
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Jacobs B, Ullrich E. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions? Curr Med Chem 2012; 19:1771-9. [PMID: 22414086 DOI: 10.2174/092986712800099857] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2011] [Revised: 12/06/2011] [Accepted: 12/07/2011] [Indexed: 11/22/2022]
Abstract
The crosstalk of natural killer (NK) and dendritic cells (DCs) plays an important role in the induction of the tumor-specific immune response against cancer. During the last decade, our advanced understanding of the immune system led to the development of new therapeutic strategies in the field of immunotherapy and cellular immunology. However, these immunotherapeutic concepts have not been as successful as initially expected because of their inability to counteract cancer-induced immunosuppressive pathways. Some of the major difficulties of effective cellular immunotherapy are the highly immunosuppressive factors induced by tumor cells themselves or by their microenvironment. Therefore, one major challenge in immunotherapy is the question: "How to enforce NK cell & DC action under immunosuppressive conditions?" This review focuses on the current knowledge on the tumor microenvironment, the crosstalk of NK cells and DCs, as well as their deregulation in the complex interplay with the immunosuppressive tumor microenvironment. We further discuss possible strategies to minimize the negative impact of the tumor microenvironment on the immune system.
Collapse
Affiliation(s)
- B Jacobs
- Department of Internal Medicine 5 - Hematology/Oncology, University of Erlangen-Nurnberg, Ulmenweg 18, 91054 Erlangen, Germany
| | | |
Collapse
|
12
|
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Mignot G, Ullrich E, Kroemer G, Zitvogel L. Cancer is not just a disease of a tissue: it is a host disease. How to reactivate host defense against tumors using conventional therapies of cancer? Ann Endocrinol (Paris) 2008; 69:151-2. [PMID: 18420177 DOI: 10.1016/j.ando.2008.02.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- L Apetoh
- Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif, France
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Abstract
Exosomes are nanometer particles (50-100 nm) secreted by most living cells. The first description of exosomes was made in 1987 by Rose Johnstone, who described a vesicle formation during the maturation process of reticulocytes. At this time it has been suggested that exosome release could represent a major route for the externalization of obsolete membrane proteins. A renewed vision of exosome function was raised when Graça Raposo demonstrated in 1996 that exosomes derived from B cells could have immunogenic capacities. Since then, exosomes have been described in numerous cell types IN VITRO, including hematopoietic and nonhematopoietic cells. The physiological relevance of exosomes IN VIVO still remains unclear. Studies have demonstrated that exosomes can play a role in the physiology of originating cells (i.e., reticulocyte-derived exosomes). Furthermore, exosomes can act on intercellular communication by allowing exchange of proteins, lipids, and also mRNA between cells. Finally, exosomes have been shown to modulate the immune system (i.e., dendritic cells, B cells, and tumor cells). In the present review, we have focused on the potential therapeutic role of exosomes as a cell free vaccine in cancer.
Collapse
Affiliation(s)
- S Viaud
- Institut National de la Santé Et de la Recherche Médicale, INSERM U805, Institut Gustave Roussy, Villejuif, France
| | | | | | | |
Collapse
|
14
|
Abstract
Tumor immunosurveillance is mediated by innate and adaptive components of cellular immunity. A complex network of cellular interactions is needed to elicit protective antitumoral CD4+and CD8+T cell responses. Thereby dendritic cells (DCs) play a central role as professional antigen presenting cells (APCs) that take up antigens, process, and present them to prime naïve T cells. Recognition and lysis of tumor cells has been attributed to innate effectors such as natural killer (NK), NKT and gammadeltaT cells. Recently, novel subsets of cytotoxic DCs, called "killer DCs" (KDCs), have been reported in rodents and humans. Killer dendritic cells could directly link innate and adaptive immunity. This review aims at comparing the different KDC populations, their phenotypes, killer function, and their potential application for anticancer immunotherapy.
Collapse
Affiliation(s)
- E Ullrich
- Institut Gustave Roussy, Villejuif, France
| | | | | |
Collapse
|
15
|
Abstract
A cornucopia of physiological and pathological circumstances including anticancer chemotherapy and radiotherapy can induce cell death. However, the immunological consequences of tumor cell demise have remained largely elusive. The paradigm opposing 'apoptosis versus necrosis' as to their respective immunogenicity does not currently hold to predict long-term immunity. Moreover, the notion that tumor cells may be 'stressed' before death to be recognized by immune cells deserves to be underlined. 'Eat-me', 'danger' and 'killing' signals released by stressed tumor under the pressure of cytotoxic compounds may serve as links between the chemotherapy-elicited response of tumor cells and subsequent immune responses. This review will summarize the state-of-the-art of cancer immunity and describe how tumor cell death dictates the links between innate and acquired immunity.
Collapse
Affiliation(s)
- E Ullrich
- INSERM U805, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille Desmoulins, Villejuif, France
| | | | | | | | | |
Collapse
|
16
|
Engelhardt OG, Ullrich E, Kochs G, Haller O. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Exp Cell Res 2001; 271:286-95. [PMID: 11716541 DOI: 10.1006/excr.2001.5380] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Mx proteins are interferon-induced large GTPases, some of which have antiviral activity against a variety of viruses. The murine Mx1 protein accumulates in the nucleus of interferon-treated cells and is active against members of the Orthomyxoviridae family, such as the influenza viruses and Thogoto virus. The mechanism by which Mx1 exerts its antiviral action is still unclear, but an involvement of undefined nuclear factors has been postulated. Using the yeast two-hybrid system, we identified cellular proteins that interact with Mx1 protein. The Mx1 interactors were mainly nuclear proteins. They included Sp100, Daxx, and Bloom's syndrome protein (BLM), all of which are known to localize to specific subnuclear domains called promyelocytic leukemia protein nuclear bodies (PML NBs). In addition, components of the SUMO-1 protein modification system were identified as Mx1-interacting proteins, namely the small ubiquitin-like modifier SUMO-1 and SAE2, which represents subunit 2 of the SUMO-1 activating enzyme. Analysis of the subcellular localization of Mx1 and some of these interacting proteins by confocal microscopy revealed a close spatial association of Mx1 with PML NBs. This suggests a role of PML NBs and SUMO-1 in the antiviral action of Mx1 and may allow us to discover novel functions of this large GTPase.
Collapse
Affiliation(s)
- O G Engelhardt
- Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Freiburg, D-79008, Germany.
| | | | | | | |
Collapse
|
17
|
Hoffmann E, Lüdke C, Skole J, Stephanowitz H, Ullrich E, Colditz D. Spatial determination of elements in green leaves of oak trees (Quercus robur) by laser ablation-ICP-MS. Fresenius J Anal Chem 2000; 367:579-85. [PMID: 11225835 DOI: 10.1007/s002160000429] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Laser ablation inductively coupled plasma mass spectrometry (laser ablation-ICP-MS) has been applied to the spatially resolved determination of the elements Mg, Ca, Cu, Ni, Ba, Al, Pb, Sr and Mn in green leaves of oak trees. Instrument operating parameters such as the laser wavelength and the pulse energy have been optimized to provide the sensitivity and reproducibility required for the analysis. The method provides spatial resolution down to 300 microm with the use of the 355 nm wavelength (3rd harmonic of the 1,064 nm Nd:YAG laser wavelength) and the pulse energy of 50 mJ. Plant standards and cellulose, doped with multi element solution standards, dried and pressed to pellets were used as calibration samples. To compensate for signal fluctuations caused by the variation of the ablated sample mass 13C was used as a "natural" internal standard. The accuracy of the calibration was verified with selected samples analyzed by ICP-MS (high pressure digestion, 170 degrees C, 10(7) Pa, HNO3, 2 h) and by laser ablation-ICP-MS. Recovery rates between 93% (Cu) and 108% (Mn) were obtained. Leaves taken from oak trees (Quercus robur) were analyzed.
Collapse
Affiliation(s)
- E Hoffmann
- Institut für Spektrochemie und angewandte Spektroskopie, Berlin, Germany.
| | | | | | | | | | | |
Collapse
|
18
|
Lüdke C, Hoffmann E, Skole J, Ullrich E. Solar blind photocell--a simple element specific detector in Hg, As and Se speciation. Fresenius J Anal Chem 2000; 366:204-8. [PMID: 11225929 DOI: 10.1007/s002160050040] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
An element-specific detection method, based on atomic absorption spectrometry (AAS) using solar blind photocells instead of a dispersion system, is described for the determination of Hg-, As-, and Se-species. Spectrometric investigations of AAS background lamps for As and Se measured with a CsI-cathode photocell shows its quality as narrow band detector. Species determination can be carried out subsequently to prior separation by HPLC or GC. The LODs for alkylated Hg species were below 1 ng/L, and for methylated As species below 1 microg/L. The relative standard deviation was < 10%. With the components described the production of cheap and automated dedicated speciation spectrometers is possible.
Collapse
Affiliation(s)
- C Lüdke
- Institut für Spektrochemie und angewandte Spektroskopie, Berlin-Adlershof, Germany
| | | | | | | |
Collapse
|
19
|
Warth R, Hamm K, Bleich M, Kunzelmann K, von Hahn T, Schreiber R, Ullrich E, Mengel M, Trautmann N, Kindle P, Schwab A, Greger R. Molecular and functional characterization of the small Ca(2+)-regulated K+ channel (rSK4) of colonic crypts. Pflugers Arch 1999; 438:437-44. [PMID: 10519135 DOI: 10.1007/s004249900059] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Colonic crypt cells possess basolateral Ca(2+)-regulated K+ channels which support Cl- secretion by providing the necessary driving force. The pharmacological characteristics of these channels were examined in Ussing chamber experiments of rat and rabbit colon mucosa by the use of blockers. The chromanol 293B, a blocker of KVLQT1 channels, and clotrimazole (CTZ), a blocker of small Ca(2+)-activated K+ channels, blocked stimulated Cl- secretion completely. Small-conductance Ca(2+)-activated K+ channels (SK) in excised basolateral patches of rat colonic crypts were inhibited concentration dependently by the imidazoles CTZ, NS004 and NS1619 and activated by 1-EBIO. These properties are similar to those of the known human SK channel (hSK4). hSK4-expressing Xenopus laevis oocytes showed ionomycin-activated and CTZ-inhibited K+ currents. When P2Y2 receptors were coexpressed these currents were also activated by ATP. The concentration/response curve was identical to that of rat SK channels. In human colonocytes (T84) exposed to hSK4 antisense probes, but not to sense probes, carbachol-induced K+ currents were attenuated. With RT-PCR an hSK4 could be demonstrated in human colon and in T84 colonocytes. By homology cloning the SK of the rat colon (rSK4) was identified. This protein has a high homology to hSK4 and mouse IK1. These data indicate that the Ca(2+)-activated and imidazole-inhibited basolateral K+ current in the colon is caused by SK4 channels.
Collapse
Affiliation(s)
- R Warth
- Physiologisches Institut, Albert-Ludwigs-Universität, Freiburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Vissiennon T, Schüppel KF, Ullrich E, Kuijpers AF. Case report. A disseminated infection due to Chrysosporium queenslandicum in a garter snake (Thamnophis). Mycoses 1999; 42:107-10. [PMID: 10394858 DOI: 10.1046/j.1439-0507.1999.00409.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A male garter snake (Thamnophis) from a private terrarium was spontaneously and simultaneously infected with Chrysosporium queenslandicum and Geotrichum candidum. The autopsy revealed disseminated mycotic alterations in skin, lungs and liver. Chrysosporium queenslandicum grew well at 28 degrees C, the optimal temperature of the animal. This is the first description of a Chrysosporium queenslandicum infection in a garter snake.
Collapse
|
21
|
Ullrich E, Selbitz HJ, Schieck R, Friedrich U, Schulz J. [Possibilities of clinico-cytological diagnosis in contagious equine metritis (CEM)]. Berl Munch Tierarztl Wochenschr 1991; 104:167-72. [PMID: 1872793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Clinical, bacteriological and serological examinations on a 6 years old pony mare were performed. Cytological alterations in the genital tract were also recorded. A cellular reaction was seen after infection with T. equigenitalis. This reaction is an evidence for infection but it is not specific for this organism. Cytological studies should be performed on mares especially in cases of latent infections to complete bacteriological examination and to prevent false positive or negative results.
Collapse
Affiliation(s)
- E Ullrich
- Wissenschaftsbereich Mikrobiologie und Tierseuchen, Veterinärmedizinischen Fakultät, Karl-Marx-Universität Leipzig
| | | | | | | | | |
Collapse
|
22
|
Witkowski R, Ullrich E, Pietsch P, Weber K, Heller K, Losanowa T, Nitz I. [Infant hypotonia, obesity, hypogenitalism and oligophrenia--new viewpoints on the etiology and symptoms of Prader-Willi syndrome]. Psychiatr Neurol Med Psychol (Leipz) 1985; 37:255-61. [PMID: 4023109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
We present four cases of Prader-Willi syndrome. Two of them have an abnormality of a chromosome 15, the other both show different chromosomal abnormalities. Translocations or deletions were found recently in the bands 15q11/12 in about 60% of the cases of Prader-Willi syndrome. The consequences for diagnosis, symptomatology and genetic counselling of the syndrome are discussed.
Collapse
|
23
|
Lenz W, Ullrich E, Witkowski R, Opitz C. [Unilateral incontinentia pigmenti in a male patient (author's transl)]. Padiatr Padol 1982; 17:187-199. [PMID: 7201624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
24
|
Leisztner L, Nagy L, Ullrich E. Splitless headspace gas chromatography with capillary column using automatic electropneumatic injection. ACTA ACUST UNITED AC 1982. [DOI: 10.1002/jhrc.1240050109] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
25
|
Bauch K, Witkowski R, Ullrich E, Dempe A, Lindner J. The XX male -- report on a child and an adult. Endokrinologie 1980; 76:63-7. [PMID: 7192212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Two XX males are described. The first patient with a typical phenotype of XX males has aplasia of the left kidney. The second one is a boy, who shows an additional chromosome translocation and also signs of the Prader-Willi syndrome.
Collapse
|
26
|
Véghelyi P, Leisztner L, Osztovics M, Korányi G, Kardos G, Ullrich E. [Development of the fetal alcohol syndrome]. Orv Hetil 1980; 121:133-5. [PMID: 7366977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
27
|
Witkowski R, Ullrich E. [Hypogonadism and intersexuality--genetic causes and cytogenetic diagnosis]. Z Gesamte Inn Med 1979; 34:601-5. [PMID: 549296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Hereditary types of hypogonadism and intersexuality are based on a chromosomal aberration, on a monogenetic defect of androgen synthesis, or on a androgen receptor. Cytogenetic diagnostic methods are suitable mainly for diagnosis of gonosomally caused syndromes. Monogenic defects have to be proved on the basis of the known karyotype by endocronologie techniques.
Collapse
|
28
|
Abstract
We present a boy with the karyotype 46,XY,r3 and a phenotype with psychomotor and growth retardation, craniofacial anomalies, syndactyly of the toes, and edema of the feet. The karyotypes and phenotypes of both parents are normal.
Collapse
|
29
|
M�ller FH, Brendel B, Jost W, Wagner HG, Scheibe G, Hoyer H, Scheele W, Schmillen A, Stauff J, Gross, Grubhofer N, Ullrich E, Schultze HE. B�cherbesprechungen. Colloid Polym Sci 1955. [DOI: 10.1007/bf01524495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|